Why Suppository Packaging Matters: Ensuring Medication Integrity and Compliance | Suppository Packaging Market Demand, Size, & Growth Analysis
Suppository packaging refers to specialized containers designed to safely and effectively store and protect suppositories—medications intended for insertion into the body. This packaging ensures the product's integrity, preventing contamination and degradation. Typically made from materials like plastic or aluminum, suppository packaging is designed for convenience and ease of use, often featuring individual compartments to keep each suppository hygienic and ready for application.
The suppository packaging market is projected to reach USD 428 million by 2029, at a CAGR of 6.5% from USD 312 million in 2024. The growth of the global suppository packaging market is driven by growing geriatric population, increased focus on patient convenience, increasing demand for child-resistant packaging, and rising prevalence of chronic diseases.
Download PDF Brochure: https://bit.ly/3M3ccgQ
What are the main applications of suppository packaging in the pharmaceutical industry??
Suppository packaging plays a crucial role in the pharmaceutical industry by ensuring the safe and effective delivery of medications intended for rectal or vaginal administration. It is primarily used for packaging medications like pain relievers, anti-nausea drugs, and hormone treatments, as well as certain specialized treatments such as pediatric and geriatric medicines. The packaging provides protection against contamination and degradation, maintains hygiene, and facilitates ease of use for both healthcare professionals and patients. Additionally, it often features tamper-evident and child-resistant designs to enhance safety and compliance.?
What are the key trends driving the growth of the suppository packaging market??
? Rising Demand for Over-the-Counter (OTC) Suppositories: Increased consumer preference for self-medication and OTC products is fueling the demand for convenient and discreet packaging solutions.?
? Advancements in Packaging Technology: Innovations such as child-resistant and tamper-evident packaging enhance safety and user confidence, driving market growth.?
? Growing Focus on Hygiene and Safety: Increased awareness about hygiene and the need to protect sensitive medications are leading to higher demand for packaging that ensures product integrity.?
? Expansion of Healthcare and Pharmaceutical Markets: The growth in healthcare infrastructure and the pharmaceutical industry's expansion, particularly in emerging markets, boosts the need for effective packaging solutions.?
? Customization and Branding: Advances in packaging design and customization allow for better branding and differentiation, appealing to both manufacturers and consumers.?
? Sustainability Trends: There is a growing emphasis on environmentally friendly packaging materials, driving the development of sustainable options in the suppository packaging sector.
Suppository Packaging Market Segmentation
? Based on the material:
Aluminum/PE is the second largest material of the suppository packaging, in terms of value
Aluminum/PE material effectively minimizes the risk of suppositories from moisture, oxygen, light and other factors leading to degradation and thus maintaining the stability and effectiveness of suppositories. This material is very durable and strong which can withstand the normal handling and transportation processes without affecting the contents. Furthermore, the material is flexible hence has the ability to be formed into various shapes and sizes hence area ability to adopt to different dimensions of suppositories. In regards to heat sealing abilities polyethylene has the best which guarantees a tight and hermetic seal on the suppositories to enhance their sterility and quality. Aluminum/PE packaging is also relatively cheaper, and provides a good combination of high performance and reasonable production costs, which make it popular among manufacturers. It is commonly used in pharma market to meet the necessary standards of safety and quality, thus, providing effective solution for suppository packaging.
? Based on the application:
Get Sample Copy of this Report:?https://bit.ly/3AnqiXZ
? Based on the region:
领英推荐
Europe captures the second largest share in the suppository packaging market during the forecast period, in terms of value
The high level of medical care and well-developed healthcare system in the Europe fuels the need for efficient and quality pharmaceutical packaging. Most European countries have an aging population which leads to the demand for various treatments including those by use of suppositories. Additionally, due to the strict health standards of Europe, especially in the packaging of drugs and medication, only the best packaging material and technique is used. Furthermore, Europe’s emphasis on sustainability and reduction of environmental effects encourages the utilization of environmentally-friendly packaging materials to fuel the market. The well-established regional market of pharmaceuticals along with increased spends on research and development fuels innovation in packaging methods thus boosting the overall market growth.
Suppository Packaging Market Trending Key Players
?? NextPharma Technologies (UK)
?? Corden Pharma - A Full-Service CDMO (Switzerland)
?? Recipharm AB (Sweden)
?? Valmatic srl (Italy)
?? SARONG Spa (Italy)
?? Key International (US)
?? HySum Flexibles Europe GmbH (Germany)
?? FAMAR Health Care Services (Greece)
?? Hudi Pharma HQ (Italy)
?? Adragos Pharma (Germany)
?? LGM Pharma (US)
?? Aluberg S.p.a. (Italy)
?? Delpharm (France)
?? Unither Pharmaceuticals (France)
?? Trefoil Packaging Private Limited (India)?
Get 10% Customization on this Report:?https://bit.ly/4fzdsWy
Recent Developments
In February 2022, CordenPharma completed the acquisition of three manufacturing facilities from Vifor Pharma, to be renamed CordenPharma Fribourg S.A. (including its Ettingen branch) in Switzerland, and CordenPharma Lisbon S.A. in Portugal. The acquisition increased CordenPharma's production capacity for non-sterile drug product dosage forms, including tablets and capsules that are part of the oral solid dose (OSD) form. Suppositories, suspensions, enemas, and ear drops are all exclusively made at the Ettingen location.
In March 2023, Adragos Pharma has acquired the Sanofi production site in Kawagoe, Japan, marking a significant expansion for the German contract development and manufacturing organization (CDMO). This acquisition positions Adragos as the third-largest pure-play CDMO in the Japanese market. The Kawagoe facility, one of Japan's largest and most advanced manufacturing sites, specializes in producing oral solids and sterile liquids, as well as providing packaging and quality control services for the Japanese and Asian markets.
In April 2024, Delpharm has expanded its presence in the Netherlands by acquiring state-of-the-art drug production facilities from Astellas. This expansion helps Delpharm to enhance its capabilities and expand its service offerings to provide comprehensive solutions to its customers in the pharmaceutical industry.